(Q39690702)

14 September 2017

title

Potential of bacteriophages and their lysins in the treatment of MRSA: current status and future perspectives (English)

1 reference

14 September 2017

1 reference

Beata Weber-Dąbrowska

series ordinal

4

object named as

Beata Weber-Dabrowska

1 reference

14 September 2017

1

Jan Borysowski

1 reference

14 September 2017

5

Andrzej Górski

1 reference

14 September 2017

Ryszard Międzybrodzki

series ordinal

3

object named as

Ryszard Międzybrodzki

1 reference

14 September 2017

Małgorzata Lobocka

2

1 reference

14 September 2017

publication date

1 December 2011

1 reference

14 September 2017

1 reference

14 September 2017

volume

25

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

347-355

1 reference

https://scigraph.springernature.com/pub.10.2165/11595610-000000000-00000

14 September 2017

exact match

0 references

cites work

The future of bacteriophage biology

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

21 January 2018

Bacteriophage therapy

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Bacteriophage lysins as effective antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

“Celbenin” - resistant Staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Waves of resistance: Staphylococcus aureus in the antibiotic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Antimicrobial resistance: it's not just for hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

MRSA: an evolving pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Antibiotic-resistant bugs in the 21st century--a clinical super-challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

The prospect for bacteriophage therapy in Western medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Preventing biofilms of clinically relevant organisms using bacteriophage

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

5500 Phages examined in the electron microscope

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Curated list of prokaryote viruses with fully sequenced genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

First complete genome sequence of two Staphylococcus epidermidis bacteriophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Two different Panton-Valentine leukocidin phage lineages predominate in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Microbiological and molecular assessment of bacteriophage ISP for the control of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

The SPO1-related bacteriophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

The genome of Bacillus subtilis bacteriophage SPO1

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Wide host range and strong lytic activity of Staphylococcus aureus lytic phage Stau2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Isolation from sewage influent and characterization of novel Staphylococcus aureus bacteriophages with wide host ranges and potent lytic capabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

The effects of staphylococcal bacteriophage lysates on cancer cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

21 January 2018

Phi29 family of phages

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Unifying classical and molecular taxonomic classification: analysis of the Podoviridae using BLASTP-based tools

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Bacteriophage typing of enteric pathogens and staphylococci and its use in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of staphylococcus bacteriophage K.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Synonymous codon usage bias in 16 Staphylococcus aureus phages: implication in phage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Role of RNA in bacteriophage phi 29 DNA packaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

The terminally redundant, nonpermuted genome of Listeria bacteriophage A511: a model for the SPO1-like myoviruses of gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Genome and proteome of Listeria monocytogenes phage PSA: an unusual case for programmed + 1 translational frameshifting in structural protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Long-circulating bacteriophage as antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Identification of bacteriophage types and their carriage in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Purification and characterization of repressor of temperate S. aureus phage phi11.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Sau42I, a BcgI-like restriction-modification system encoded by the Staphylococcus aureus quadruple-converting phage Phi42.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Common themes among bacteriophage-encoded virulence factors and diversity among the bacteriophages involved

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Isolation and characterization of a novel Staphylococcus aureus bacteriophage, phiMR25, and its therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Development of a novel targeting system for lethal photosensitization of antibiotic-resistant strains of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Experimental phage therapy against Staphylococcus aureus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Toward modern inhalational bacteriophage therapy: nebulization of bacteriophages of Burkholderia cepacia complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

The potential of phages to prevent MRSA infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Tail-associated structural protein gp61 of Staphylococcus aureus phage phi MR11 has bifunctional lytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

The two-component lysis system of Staphylococcus aureus bacteriophage Twort: a large TTG-start holin and an associated amidase endolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Phage P68 virion-associated protein 17 displays activity against clinical isolates of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Antimicrobial activity of a chimeric enzybiotic towards Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595610-000000000-00000

10.2165/11595610-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

14 September 2017

1053711471

0 references

1 reference